Technical Analysis for CATB - Catabasis Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade B 7.96 -3.52% -0.29
CATB closed down 3.52 percent on Friday, May 17, 2019, on 87 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical CATB trend table...

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
BB Squeeze + Upper Band Touch Range Contraction 0.00%
Upper Bollinger Band Touch Strength 0.00%
MACD Bullish Signal Line Cross Bullish -3.52%
Bollinger Band Squeeze Range Contraction -3.52%
BB Squeeze + Upper Band Touch Range Contraction -3.52%
Upper Bollinger Band Touch Strength -3.52%
20 DMA Support Bullish -6.35%
MACD Bullish Centerline Cross Bullish -6.35%
Pocket Pivot Bullish Swing Setup -6.35%

Older signals for CATB ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Catabasis Pharmaceuticals, Inc. (Catabasis) is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of therapeutics based on its safely metabolized and rationally targeted (SMART) linker technology platform. Its SMART linker technology platform is based on the concept of treating diseases by simultaneously modulating various biological targets in one or more related disease pathways. Catabasis engineers bi-functional product candidates that are conjugates of two molecules, or bioactives, each with known pharmacological activity, joined by one of its SMART linkers. Catabasis is also engaged in developing other product candidates for the treatment of lipid disorders. The Company's product development pipeline includes three clinical-stage product candidates, namely, CAT-1004, CAT-2000 series, including CAT-2054 and CAT-2003, and CAT-4001, and various programs in preclinical development.
Biopharmaceutical Diseases Lipid Disorders Cat
Is CATB a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 17.6
52 Week Low 3.6
Average Volume 202,475
200-Day Moving Average 6.6196
50-Day Moving Average 7.69
20-Day Moving Average 7.8565
10-Day Moving Average 7.861
Average True Range 0.508
ADX 20.33
+DI 25.7649
-DI 16.7356
Chandelier Exit (Long, 3 ATRs ) 7.376
Chandelier Exit (Short, 3 ATRs ) 8.784
Upper Bollinger Band 8.4146
Lower Bollinger Band 7.2984
Percent B (%b) 0.59
BandWidth 14.207344
MACD Line 0.0748
MACD Signal Line 0.0606
MACD Histogram 0.0142
Fundamentals Value
Market Cap 178.95 Million
Num Shares 22.5 Million
EPS -1.71
Price-to-Earnings (P/E) Ratio -4.65
Price-to-Sales 0.00
Price-to-Book 2.17
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.85
Resistance 3 (R3) 8.93 8.71 8.70
Resistance 2 (R2) 8.71 8.49 8.67 8.65
Resistance 1 (R1) 8.34 8.35 8.23 8.26 8.60
Pivot Point 8.12 8.12 8.07 8.08 8.12
Support 1 (S1) 7.75 7.90 7.64 7.67 7.32
Support 2 (S2) 7.53 7.76 7.49 7.27
Support 3 (S3) 7.16 7.53 7.22
Support 4 (S4) 7.08